ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
BiotechIPO DateHeadquartersTickerShs SoldIPO $/ShIPO ProceedsInsider %Insider DollarsInsider OptionalIPO SEC LinkDate FoundedPre-IPO SharesIPO Pre- MoneyShs Post-IPOPost IPO Mkt CapMost AdvancedPlatformTherapeutic Area
2
Acumen Pharmaceuticals30-Jun-21VirginiaABOS10.00$16.00$160.00Link199628.65$458.438.7$618.40Phase IMonoclonalsCNS, Alzheimers MOA
3
Aerovate Therapeutics29-Jun-21MassAVTE8.68$14.00$121.52Link201814.40$201.623.1$323.12Phase INoneCardio pulmonary formulation
4
Acurx Pharmaceuticals24-Jun-21New YorkACXP2.50$6.00$15.00Link20177.00$42.09.5$57.00Phase IINoneAntibiotics MOA
5
Alpha Teknova24-Jun-21NorCalTKNO6.00$16.00$96.00Link199621.10$337.627.1$433.60MktCell cultureReagents
6
Elevation Oncology24-Jun-21New YorkELEV6.25$16.00$100.00Link201916.60$265.622.9$365.60Phase IINoneCancer MOA
7
GH Research24-Jun-21IrelandGHRS10.00$16.00$160.00Link201840.50$648.050.5$808.00Phase IINoneCNS Psychiatric
8
Graphite Bio24-Jun-21NorCalGRPH14.00$17.00$238.00Link201742.00$714.056.0$952.00PreclinicalGene editingGenetic diseases
9
Miromatrix Medical23-Jun-21MinnesotaMIRO4.80$9.00$43.20Link200913.40$120.618.2$163.80Preclinical
Bioengineered organs
Transplantation
10
Ambrx Biopharma17-Jun-21SoCalAMAM7.00$18.00$126.00Link200330.70$552.637.7$678.60Phase IIIMonoclonal ADCCancer MOA
11
ATAI Life Sciences17-Jun-21NetherlandsATAI15.00$15.00$225.00Link2018137.60$2,064.0152.6$2,289.00Phase IINoneCNS Psychiatric
12
Codex DNA17-Jun-21SoCalDNAY6.67$16.00$106.72Link201121.50$344.028.2$450.72MktSynthetic biologyDevices & reagents
13
Cyteir Therapeutics17-Jun-21MassCYT7.40$18.00$133.20Link201227.10$487.834.5$621.00Phase ISynthetic lethalityCancer MOA
14
Lyell Immunopharma16-Jun-21NorCalLYEL25.00$17.00$425.00Link2018217.80$3,702.6242.8$4,127.60Preclinical
T cell immunotherapy
Cancer MOA
15
Verve Therapeutics16-Jun-21MassVERV14.00$19.00$266.0028%$74.48YesLink201832.10$609.946.1$875.90PreclinicalGene editingCardiiovascular MOA
16
Molecular Partners AG15-Jun-21SwitzerlandMOLN3.00$21.25$63.75Link200429.20$620.532.2$684.25Phase IIIMonoclonal ADCInfection & cancer MOA
17
Alzamend Neuro14-Jun-21FloridaALZN2.50$5.00$12.5080%$10.00Link201682.40$412.084.9$424.50PreclinicalNoneAlzheimer's
18
Janux Therapeutics10-Jun-21SoCalJANX11.40$17.00$193.80Link201728.50$484.539.9$678.30Preclinical
T cell immunotherapy
Cancer MOA
19
Centessa Pharmaceuticals
27-May-21LondonCNTA16.50$20.00$330.00Link202070.70$1,414.087.2$1,744.00Phase IIINoneMultiple diseases
20
Day One Biopharmaceuticals
26-May-21NorCalDAWN10.00$16.00$160.00Link201850.40$806.460.4$966.40Phase IINoneCancer MOA
21
Vera Therapeutics13-May-21NorCalVERA4.35$11.00$47.85Link201616.13$177.420.5$225.28Phase IINoneAutoimmune diseases
22
Anebulo Pharmaceuticals06-May-21TexasANEB3.00$7.00$21.0030%$6.30Link202020.27$141.923.3$162.89Phase INoneCNS, Addiction
23
Talaris Therapeutics06-May-21KentuckyTALS8.83$17.00$150.03Link200232.42$551.141.2$701.17Phase IIcell therapyKidney disease
24
Valneva05-May-21FranceVALN3.54$26.41$93.49Link199945.40$1,199.048.9$1,292.51Phase IIVaccine designLyme disease vaccine
25
Vaccitech29-Apr-21Oxford UKVACC6.50$17.00$110.50Link201627.56$468.534.1$579.02Phase IIDrug designInfections & Cancer MOA
26
Werewolf Therapeutics29-Apr-21MassHOWL7.50$16.00$120.00Link201720.04$320.627.5$440.64PreclinicalDrug designCancer MOA
27
Protagenic Therapeutics26-Apr-21New YorkPTIX3.18$4.15$13.20Link200610.60$44.013.8$57.19PreclinicalNoneCNS, Depression
28
Impel NeuroPharma22-Apr-21SeattleIMPL5.33$15.00$79.95Link200814.08$211.219.4$291.15FiledNasal deliveryCNS, Migraines
29
Rain Therapeutics22-Apr-21NorCalRAIN7.35$17.00$124.95Link201718.62$316.526.0$441.49Phase IDrug designCancer MOA
30
Zymergen21-Apr-21NorCalZY16.13$31.00$500.03Link201381.81$2,536.197.9$3,036.14MktMicrobial manuBiofilm
31
Akoya Biosciences15-Apr-21MassAKYA6.58$20.00$131.60Link201529.11$582.235.7$713.80MktDiagnosticBiomarkers
32
Biomea Fusion15-Apr-21NorCalBMEA9.00$17.00$153.00Link201719.77$336.128.8$489.09PreclinicalDrug designCancer MOA
33
Recursion Pharmaceuticals
15-Apr-21Salt Lake CityRXRX24.24$18.00$436.3229%$124.79Link2013137.92$2,482.6162.2$2,918.88Phase IBioinformaticsMultiple
34
Reneo Pharmaceuticals08-Apr-21SoCalRPHM6.25$15.00$93.75Link201417.96$269.424.2$363.15Phase IIGenetic diseasesMitochondrial diseases
35
VectivBio Holding08-Apr-21BaselVECT7.50$17.00$127.50Link201926.51$450.734.0$578.17Phase IIIrare diseasesGI diseases
36
Achilles Therapeutics30-Mar-21LondonACHL9.75$18.00$175.50Link201630.87$555.740.6$731.16Phase I/IIDrug designCancer MOA
37
Design Therapeutics25-Mar-21SoCalDSGN12.00$20.00$240.00Link201741.82$836.453.8$1,076.40PreclinicalGenetic diseasesMuscle wasting
38
Edgewise Therapeutics25-Mar-21ColoradoEWTX11.00$16.00$176.00Link201736.57$585.147.6$761.12Phase Irare diseasesMuscle wasting
39
Ikena Oncology25-Mar-21MassIKNA7.81$16.00$124.96Link201626.78$428.534.6$553.44PreclinicalDrug designCancer MOA
40
Lava Therapeutics24-Mar-21NetherlandsLATX6.70$15.00$100.50Link201618.65$279.825.4$380.25PreclinicalBi-specific AbsCancer MOA
41
Universe Pharmaceuticals
22-Mar-21ChinaUPC5.00$5.00$25.00Link199816.00$80.021.0$105.00MktNatural productsInflammation
42
Connect Biopharma18-Mar-21ChinaCNTB11.25$17.00$191.25Link201267.07$1,140.278.3$1,331.44Phase IICellular screeningInflammation
43
Finch Therapeutics18-Mar-21MassFNCH7.50$17.00$127.50Link201439.65$674.147.2$801.55Phase IIMicrobiomeInfections
44
Instil Bio18-Mar-21TexasTIL16.00$20.00$320.00Link2018109.81$2,196.2125.8$2,516.20Preclinicalcell therapyCancer MOA
45
Gain Therapeutics17-Mar-21MarylandGANX3.64$11.00$40.04Link20177.69$84.611.3$124.63LeadGenetic diseasesLysosomal disorders
46
Longboard Pharmaceuticals
11-Mar-21SoCalLBPH5.00$16.00$80.00Link202011.92$190.716.9$270.72Phase INoneCNS
47
Prometheus Biosciences11-Mar-21SoCalRXDX10.00$19.00$190.00Link201627.25$517.837.3$707.75Phase INoneGI diseases, IBD
48
Longeveron12-Feb-21FloridaLGVN2.66$10.00$26.60Link201416.04$160.418.7$187.00Phase IIcell therapyAging frailty
49
Decibel Therapeutics11-Feb-21MassDBTX7.06$18.00$127.08Link201317.24$310.324.3$437.40PreclinicalGene TherapyHearing & balance disorders
50
NexImmune11-Feb-21MarylandNEXI6.47$17.00$109.99Link201115.08$256.421.6$366.35Phase IDrug designCancer MOA
51
Talis Biomedical11-Feb-21NorCalTLIS13.80$16.00$220.80Link201039.54$632.653.3$853.44EUA filedDiagnosticRespiratory infections
52
Angion Biomedica09-Feb-21New YorkANGN5.00$16.00$80.00Link199822.16$354.627.2$434.56Phase IIINoneKidney disease
53
Biophytis SA09-Feb-21ParisBPTS1.20$16.75$20.10Link200610.08$168.811.3$188.94Phase IINoneNeuro-muscular diseases
54
Vallon Pharmaceuticals09-Feb-21PennsylvaniaVLON2.25$8.00$18.00Link20184.51$36.16.8$54.08Phase IAbuse deterent delCNS
55
Adagene08-Feb-21ChinaADAG7.35$19.00$139.65Link201134.82$661.642.2$801.23Phase IDrug designCancer MOA
56
Vor Biopharma05-Feb-21MassVOR9.83$18.00$176.94Link201525.82$464.835.7$641.70Preclinicalcell therapyCancer MOA
57
Bolt Biotherapeutics04-Feb-21NorCalBOLT11.50$20.00$230.00Link201523.02$460.434.5$690.40Phase I/IIMonoclonal ADCCancer MOA
58
Evaxion Biotech04-Feb-21DenmarkEVAX10.00$3.00$30.00Link200816.20$48.626.2$78.60Phase I/IIDrug designCancer MOA
59
Immunocore04-Feb-21EnglandIMCR9.94$26.00$258.44Link200732.36$841.442.3$1,099.80Phase IIIBispecific MabsCancer MOA
60
Lucira Health04-Feb-21NorCalLHDX9.00$17.00$153.00Link201327.96$475.337.0$628.32EUA grantedDiagnosticRespiratory infections
61
Pharvaris BV04-Feb-21NetherlandsPHVS8.27$20.00$165.40Link201523.57$471.431.8$636.80Phase Irare diseasesangioedema
62
Terns Pharmaceuticals04-Feb-21NorCalTERN7.50$17.00$127.50Link201616.47$280.024.0$407.49Phase IINoneLiver disease, NASH
63
Landos Biopharma03-Feb-21VirginiaLABP6.25$16.00$100.00Link201732.91$526.639.2$626.56Phase IIDrug designAutoimmune diseases
64
Sana Biotechnology03-Feb-21SeattleSANA23.50$25.00$587.50Link2018160.31$4,007.8183.8$4,595.25Preclinicalcell therapyCancer MOA
65
Sensei Biotherapeutics03-Feb-21MarylandSNSE7.00$19.00$133.00Link199922.56$428.629.6$561.64Phase II
Bacteriophage Mab
Cancer MOA
66
Ortho Clinical Diagnostics27-Jan-21EnglandOCDX76.00$17.00$1,292.00Link2014146.58$2,491.9222.6$3,783.86MktDiagnosticMultiple
67
Cullinan Oncology07-Jan-21MassCGEM11.90$21.00$249.90Link201629.50$619.541.4$869.40Phase INoneCancer MOA
68
Gracell Biotechnologies07-Jan-21ChinaGRCL11.00$19.00$209.00Link201754.56$1,036.665.6$1,245.64Preclinicalcell therapyCancer MOA
69
Pharming Group22-Dec-20NetherlandsPHAR0.90$17.86$16.07Link198862.91$1,123.663.8$1,139.65MktRecombinant DNAMultiple
70
BioAtla15-Dec-20SoCalBCAB10.50$18.00$189.00Link200720.10$361.830.6$550.80Phase IIMonoclonalsCancer MOA
71
4D Molecular Therapeutics
10-Dec-20NorCalFDMT8.40$23.00$193.20Link201316.83$387.125.2$580.29Phase IGene TherapyOphthalmology
72
AbCellera Biologics10-Dec-20CanadaABCL24.15$20.00$483.0020%$96.60YesLink2012241.42$4,828.4265.6$5,311.40Phase IIIDrug designMultiple
73
Nanobiotix10-Dec-20FranceNBTX7.30$13.50$98.55Link200326.04$351.533.3$450.09Mkt in EUradiotherapyCancer
74
Sigilon Therapeutics03-Dec-20MassSGTX7.00$18.00$126.00Link201523.19$417.430.2$543.42Phase Icell therapyBlood disorders
75
Silverback Therapeutics03-Dec-20SeattleSBTX11.50$21.00$241.50Link201621.57$453.033.1$694.47Phase IMonoclonal ADCCancer MOA
76
Kinnate Biopharma02-Dec-20SoCalKNTE12.00$20.00$240.00Link201829.53$590.641.5$830.60PreclinicalDrug designCancer MOA
77
Maravai LifeSciences19-Nov-20SoCalMRVI60.00$27.00$1,620.00Link2014197.62$5,335.7257.6$6,955.74MtkOligo reagentsMultiple
78
Olema Pharmaceuticals18-Nov-20NorCalOLMA11.00$19.00$209.00Link200627.52$522.938.5$731.88Phase INoneCancer MOA
79
Atea Pharmaceuticals29-Oct-20MassAVIR12.50$24.00$300.00Link201268.24$1,637.880.7$1,937.76Phase IINucleotidesAntivirals
80
SQZ Biotechnologies29-Oct-20MassSQZ4.41$16.00$70.56Link201319.56$313.024.0$383.52Phase Icell therapyCancer & Infection
81
Galecto28-Oct-20DenmarkGLTO5.67$15.00$85.05Link201918.92$283.824.6$368.85Phase IINoneFibrotic lung disease
82
Biodesix27-Oct-20ColoradoBDSX4.00$18.00$72.00Link200522.25$400.526.3$472.50MktDiagnosticLung disease
83
Foghorn Therapeutics22-Oct-20MassFHTX7.50$16.00$120.00Link201528.20$451.235.7$571.20PreclinicalDrug designCancer MOA
84
Abcam plc21-Oct-20EnglandABCM8.95$17.50$156.63Link1998216.22$3,783.9225.2$3,940.48MktReagentsMultiple
85
Opthea16-Oct-20AustraliaOPT8.56$13.50$115.56Link198436.65$494.845.2$610.34Phase IINoneEye diseases
86
Aligos Therapeutics15-Oct-20NorCalALGS10.00$15.00$150.00Link201826.89$403.436.9$553.35Phase IoligonucleotidesViral & liver diseases
87
Kiromic Biopharma15-Oct-20TexasKRBP1.25$12.00$15.00Link20066.08$73.07.3$87.96PreclinicalCell / gene-editingCancer MOA
88
Praxis Precision Med15-Oct-20MassPRAX10.00$19.00$190.00Link201526.75$508.336.8$698.25Phase IIDrug designCNS diseases
89
Tarsus Pharmaceuticals15-Oct-20SoCalTARS5.50$16.00$88.00Link201613.76$220.219.3$308.16Phase II/IIINoneEye diseases
90
Codiak BioSciences13-Oct-20MassCDAK5.50$15.00$82.50Link201513.09$196.418.6$278.85Phase IExosome deliveryCancer & CNS
91
Kronos Bio08-Oct-20NorCalKRON13.16$19.00$250.04Link201739.88$757.753.0$1,007.76Phase IIDrug designCancer MOA
92
Shattuck Labs08-Oct-20North CarolinaSTTK11.88$17.00$201.96Link201628.08$477.440.0$679.32Phase IDrug designCancer MOA
93
Spruce Biosciences08-Oct-20NorCalSPRB6.00$15.00$90.00Link201416.26$243.922.3$333.90Phase IINoneEndocrine disorders
94
Aziyo Biologics07-Oct-20MarylandAZYO2.94$17.00$49.9840%$19.99YesLink20157.29$123.910.2$173.91Mkt
Implantable devices
Regenerative medicine
95
C4 Therapeutics01-Oct-20MassCCCC9.60$19.00$182.40Link201531.95$607.141.6$789.45PreclinicalDrug designCancer & CNS MOA
96
Immunome01-Oct-20PennsylvaniaIMNM3.25$12.00$39.0051%$19.89YesLink20066.78$81.410.0$120.36PreclinicalMonoclonalsCancer & Viral MOA
97
Oncorus01-Oct-20MassONCR5.80$15.00$87.00Link201516.05$240.821.9$327.75Phase IDrug designAntivirals MOA
98
Orphazyme A/S28-Sep-20DenmarkORPH7.62$11.00$83.82Link200927.04$297.434.7$381.26Filed
Heat shock proteins
Orphan diseases
99
Greenwich LifeSciences24-Sep-20TexasGLSI1.26$5.75$7.25Link200610.71$61.612.0$68.83Phase IINoneCancer MOA
100
Compass Pathways21-Sep-20EnglandCMPS7.50$17.00$127.50Link201727.31$464.334.8$591.77Phase IINoneDepression